RECKITT Benckiser’s targeted
relief of pain claims are causing a
stir in the industry, after the TGA
released its determination in relation
to complaints over advertising.
The furore started two years ago
when Choice awarded Nurofen a
Shonky Award for its range of
caplets for migraine, back, tension
headache and period pain whose
ingredients were identical from
product to product.
“So does the back pain version
somehow magically go straight to
your back – and only your back
– as soon as you’ve swallowed it?,”
Choice said.
This award was ...
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Aug 12
Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.
To sign up for a free subscription, click on the button at right.
